Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats
Hariom Kumar, Bhupesh Sharma
Brain Research Bulletin (2016) Vol. 124, pp. 27-39
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Synaptic Dysfunction in Neurodevelopmental Disorders Associated with Autism and Intellectual Disabilities
Huda Y. Zoghbi, Mark F. Bear
Cold Spring Harbor Perspectives in Biology (2012) Vol. 4, Iss. 3, pp. a009886-a009886
Open Access | Times Cited: 746
Blood-brain barrier regulation in psychiatric disorders
John Kealy, Chris Greene, Matthew Campbell
Neuroscience Letters (2018) Vol. 726, pp. 133664-133664
Open Access | Times Cited: 238
Metabolic Dysfunction Underlying Autism Spectrum Disorder and Potential Treatment Approaches
Ning Cheng, Jong M. Rho, Susan A. Masino
Frontiers in Molecular Neuroscience (2017) Vol. 10
Open Access | Times Cited: 124
A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism
Devahuti R. Chaliha, Matthew A. Albrecht, Mauro Vaccarezza, et al.
Developmental Neuroscience (2020) Vol. 42, Iss. 1, pp. 12-48
Open Access | Times Cited: 124
Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors
Ranjana Bhandari, Jyoti K. Paliwal, Anurag Kuhad
Advances in neurobiology (2020), pp. 97-141
Closed Access | Times Cited: 113
Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder
Anna Maria Tartaglione, Sara Schiavi, Gemma Calamandrei, et al.
Neuropharmacology (2019) Vol. 159, pp. 107477-107477
Closed Access | Times Cited: 93
Neonatal Immune Challenge with Lipopolysaccharide Triggers Long-lasting Sex- and Age-related Behavioral and Immune/Neurotrophic Alterations in Mice: Relevance to Autism Spectrum Disorders
Charllyany Sabino Custódio, Bruna Stefânia Ferreira Mello, Adriano José Maia Chaves Filho, et al.
Molecular Neurobiology (2017)
Closed Access | Times Cited: 87
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum
Julie Ouellette, Baptiste Lacoste
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 55
Memantine/Aripiprazole Combination Alleviates Cognitive Dysfunction in Valproic Acid Rat Model of Autism: Hippocampal CREB/BDNF Signaling and Glutamate Homeostasis
Sohir M Zohny, Mohamed Z. Habib, Magda I. Mohamad, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 2, pp. 464-483
Open Access | Times Cited: 22
Emerging drugs for the treatment of irritability associated with autism spectrum disorder
Ahmad Shamabadi, Hanie Karimi, Razman Arabzadeh Bahri, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 45-56
Closed Access | Times Cited: 9
Can Memantine Treat Autism? Answers from Preclinical and Clinical Studies
Sawsan Aboul‐Fotouh, Sohir M Zohny, Esraa M. Elnahas, et al.
Neuroscience & Biobehavioral Reviews (2025) Vol. 169, pp. 106019-106019
Closed Access | Times Cited: 1
Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats
Roohi Mirza, Bhupesh Sharma
Brain Research Bulletin (2019) Vol. 147, pp. 36-46
Closed Access | Times Cited: 64
Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder
Hsiao‐Ying Kuo, Fu‐Chin Liu
Biomedicines (2022) Vol. 10, Iss. 3, pp. 560-560
Open Access | Times Cited: 28
Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats
Mishra Abhishek, Rubal Singla, Rohit Kumar, et al.
Journal of Ethnopharmacology (2022) Vol. 293, pp. 115199-115199
Closed Access | Times Cited: 28
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
David Zárate-López, Ana Laura Torres-Chávez, Alma Y. Gálvez‐Contreras, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 2, pp. 260-289
Open Access | Times Cited: 19
A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress
Roohi Mirza, Bhupesh Sharma
Chemico-Biological Interactions (2019) Vol. 311, pp. 108758-108758
Closed Access | Times Cited: 53
Beneficial effects of pioglitazone, a selective peroxisome proliferator‐activated receptor‐γ agonist in prenatal valproic acid‐induced behavioral and biochemical autistic like features in Wistar rats
Roohi Mirza, Bhupesh Sharma
International Journal of Developmental Neuroscience (2019) Vol. 76, Iss. 1, pp. 6-16
Closed Access | Times Cited: 49
Prevention or Amelioration of Autism-Like Symptoms in Animal Models: Will it Bring Us Closer to Treating Human ASD?
Asher Ornoy, Liza Weinstein‐Fudim, Zivanit Ergaz
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 5, pp. 1074-1074
Open Access | Times Cited: 45
Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study
Esraa M. Elnahas, Sally A. Abuelezz, Magda I. Mohamad, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 108, pp. 110185-110185
Closed Access | Times Cited: 41
Pharmacological screening of Heartwood of Pterocarpus marsupium Roxb in stress induced neurobehavioral changes in albino Wistar rat.
Vrushali Dongare, Swati Kolhe
Brain Disorders (2025), pp. 100194-100194
Open Access
Molecular Pathology and Pharmacological Treatment of Autism Spectrum Disorder-Like Phenotypes Using Rodent Models
Hsiao‐Ying Kuo, Fu‐Chin Liu
Frontiers in Cellular Neuroscience (2018) Vol. 12
Open Access | Times Cited: 46
Selective modulator of peroxisome proliferator-activated receptor-α protects propionic acid induced autism-like phenotypes in rats
Roohi Mirza, Bhupesh Sharma
Life Sciences (2018) Vol. 214, pp. 106-117
Closed Access | Times Cited: 44
Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function
Somayyeh Mohammadi, Majid Asadi‐Shekaari, Mohsen Basiri, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 199-208
Closed Access | Times Cited: 42
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173663-173663
Closed Access | Times Cited: 36
Mini-review: Brain energy metabolism and its role in animal models of depression, bipolar disorder, schizophrenia and autism
David Kolář, Lenka Kletečková, Hana Brožka, et al.
Neuroscience Letters (2021) Vol. 760, pp. 136003-136003
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top